The scientific institution contributed to the sanitary registry, the UMTEST MSUD kit for the neonatal diagnosis of maple syrup-scented urine disease, already incorporated to the country’s neonatal screening program, its deputy director of research and development, Ariel Palenzuela, informed.
They also presented a real-time PCR essay called Sumasignal APOE to detect late-onset Alzheimer’s disease, which will soon be introduced into the national health system.
On the other hand, they highlighted the alliances sustained with China during the past year, such as the memorandum of understanding with the Beijing Institute of Technology signed in September, for the joint development of a microfluidic platform, according to the Balance 2024 Assembly held at the Victoria de Girón Faculty of Medical Sciences in Havana.
The Immunoessay Center, with 37 years of experience, is a biotechnological company whose mission is to research and develop strategies, technologies and products for the sustainable screening of metabolic, communicable and non-communicable diseases.
The deputy director of research assured that the studies are continuing and that they are working on the search for a diagnostician for Oropouche, which will allow them to be better prepared for future pandemics or diseases.
ef/arm/ro/cd
